Résultats de la recherche - 7 results
The health and economic burden of musculoskeletal disorders in Belgium from 2013 to 2018
with the highest number of cases for both men and women, followed by LBP. In the same year, MSK disorders contributed to a total of 180,746 DALY s for female and 116,063 DALY s for men. LBP appeared to ...
Living with a chronic disease: insights from patients with a low socioeconomic status
Belgium. Semi-structured interviews were conducted in chronically ill patients, selected through purposive sampling. Interviews were audio-recorded and transcribed verbatim. Analysis followed an inductive ...
Health-related quality of life in patients with non-communicable disease: study protocol of a cross-sectional survey
in Flanders (Belgium). Study participants (≥18 years) are medically diagnosed with at least one of the following diseases: cardiometabolic disorders, mental disorders and musculoskeletal disorders. ...
End-of-life communication in advanced cancer: international trends (2009-2014).
Lieve; Deliens, Luc Source: BMJ Support Palliat Care (2020) Abstract: OBJECTIVE: To examine trends in end-of-life communication with people with cancer in general practice. METHODS: Mortality follow ...
Measuring disability-adjusted life years (DALYs) due to low back pain in Malta
severity (with and without leg pain – mild, moderate, severe and most severe) and their corresponding disability weights followed values reported in the GBD study. Years lived with disability (YLD) for LBP ...
Development of a generic and open source Incidence-Prevalence-Mortality model for the assessment of chronic disease epidemiology
epidemiological parameters of a disease. It accepts data on three of the following ve inputs: incidence, remission, case fatality, mortality, and prevalence. Likewise, it allows users to manipulate options on the ...
Do more people in Europe need treatment for problems related to cocaine use? An analysis of cocaine treatment demand in 10 Western European countries
Following a recent annual European meeting on drug treatment demand, a group of experts from nine countries (Belgium, France, Germany, The Republic of Ireland, Luxembourg, The Netherlands, Spain, Switzerland, ...